Beacon Biosignals is building an AI platform for brain data to treat neurological and psychiatric diseases. Real-time information of brain activity can be captured using EEGs. EEG patterns differ depending on genetics, neurodevelopment, and disease. Beacon Biosignals are tapping into this rich network of information to develop algorithms that detect features that surpass the limit of human experts. These novel features are used to create neurobiomarkers that can be used as quantifiable endpoints for clinical trials. The use of machine learning provides unprecedented speed and accuracy.
Beacon’s EEG neurobiomarker platform therefore is engineered to accelerate clinical trials which will help to speed up the development of new treatments for patients with brain disorders.